483sOnline Subscribe

Search By Date Issued

Search By Category

Drug
Device
Clinical

Search By Company/

Clinical Investigator

Search By Region

Search By FDA Investigator

Search By Keyword

Log in to start searching through our library of thousands of 483s, or Subscribe Now to 483sOnline.com to uncover exactly what FDA Inspectors are thinking about. It’s your own personal pre-investigation intelligence tool that identifies exactly what investigators are focusing on so you can be prepared – before they show up.

Patheon France S.A.S. - June 8, 2018

Issue Date

Jun 08, 2018

Region

HQ

Category

Drug
$117.00

Patheon France S.A.S.

Contact Name

Massimo Bonalumi

Contact Title

Executive Director and General Manager

Form483 Address 1

40 Boulevard de Champaret

Form483 Address 2

Bourgoin Jallieu Cedex, Isere

Form483 City

Auvergne-Rhone-Alpes

Form483 State

Form483 Postal

38307

Form483 Country

France

Inspection Range

Jun 04, 2018 - Jun 08, 2018

Pages

2

First Observation

Procedures designed to prevent objectionable microorganisms in drug products not required to be sterile are not established and written.
Investigator(s): Alan Kurtzberg